Indicator Explainer
CEBPA Gene
This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C39598. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-19. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — CEBPA Gene (C39598)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C39598. NCI definition, reproduced without modification under CC BY 4.0.
- [Prognostic significance of CEBPA gene mutations in acute myeloid leukemia]. — Zhonghua Xue Ye Xue Za Zhi, 2026-05-01 (PMID 42409733; literature)
- Enhancing gene therapy vectors manufacturing: CEBPA as a master regulator of rAAV biogenesis. — J Biol Eng, 2026-01-20 (PMID 41559702; literature)
- A significant correlation exists between CREBBP and CEBPA gene expression in de Novo adult acute myeloid leukemia. — Sci Rep, 2025-04-11 (PMID 40216811; literature)